Aisuda (Ivarmacitinib Sulfate Tablets) – AD & RA & AS | HongKong DengYue Medicine
Generic Name/Brand Name: Ivarmacitinib Sulfate Tablets/Aisuda Indications: AD & RA & AS Dosage Form: Tablets Specification: 4 mg x 28
Search Results for Rheumatoid arthritis
Mabthera (Rituximab) – NHL/CLL | HongKong DengYue Medicine
Generic Name/Brand Name: Rituximab/Mabthera Indications: NHL, DLBCL, CLL, RA, GPA, MPA Dosage Form: Subcutaneous (SC) injection Specification: 100 mg/10 mL × 1 vial; 500 mg/50 mL × 1 vial
Solu-Medrol (Methylprednisolone Sodium Succinate) – Anti-inflammatory | HongKong DengYue Medicine
Generic Name/Brand Name: Methylprednisolone Sodium Succinate / Solu-Medrol Indications: Inflammation, allergic reactions, and autoimmune or immune-mediated conditions Dosage Form: Injectable powder for intravenous (IV) or intramuscular (IM) use Specification: 40 mg/125 mg/500 mg/1 g/2 g × 1 vial
Taiai (Telitacicept) – SLE | HongKong DengYue Medicine
Generic Name/Brand Name: Telitacicept/Taiai Indications: Autoantibody-positive systemic lupus erythematosus (SLE) Dosage Form: Lyophilized powder for subcutaneous injection Specification: 80 mg x 1 vial
Plaquenil (Hydroxychloroquine Sulfate) – Autoimmune | HongKong DengYue Medicine
Generic Name/Brand Name: Hydroxychloroquine Sulfate / Plaquenil® Indications: Malaria, RA, SLE Dosage Form: Tablet Specification: 100 mg × 14 tablets/box
Can Mavorixafor Improve Quality of Life for Children with pLGG?
Xolremdi(mavorixafor) is an innovative pharmaceutical compound that has gained significant attention in the medical and biotech industries. As a potential game-changer in targeted therapies, Xolremdi is being studied for its unique mechanism of action and broad applications in treating chronic…
Why is Nogapendekin alfa inbakicept-pmln Generating Excitement in Bladder Cancer Immunotherapy?
Anktiva(nogapendekin alfa inbakicept-pmln) is a cutting-edge therapeutic agent that has garnered significant attention in the medical and biotech communities. Understanding Anktiva’s mechanisms, applications, and benefits is crucial for healthcare professionals, researchers, and others exploring new treatment options. This article provides…
Kineret (Anakinra) For The Treatment Of COVID-19-Associated Pneumonia Expands Its Immunomodulatory Applications
The U.S. Food and Drug Administration (FDA) has expanded its approval of Sobi’s (Swedish Orphan Biovitrum AB) Kineret® (anakinra) for the treatment of patients with pneumonia caused by COVID-19, especially those at risk of progression to severe respiratory failure. This…
Recombinant｜Acute Lymphoblastic Leukaemia｜HongKong DengYue Medicine
Generic Name/Brand Name: Recombinant/Rylaze Indications: Acute Lymphoblastic Leukaemia Dosage Form: Injection Specification: 10mg
New Immunotherapy Drugs: Iparomlimab And Tuvonralimab Injection Show Promising Results In Clinical Trials
February 25, 2025 – In an exciting advancement in immunotherapy, the combination of Iparomlimab and Tuvonralimab injection is demonstrating significant efficacy in the treatment of multiple cancers and autoimmune diseases, according to recent clinical trial results. Iparomlimab In Cancer Immunotherapy…
Copyright@ 2016-2024 Hong Kong Deng Yue Med Al Rights